Objective: Currently published data regarding the potential role of osteoprotegerin (OPG),
osteocalcin (OCN) and osteopontin (OPN) for the discrimination between rheumatoid …

This study aimed to systemically review the evidence regarding the relationship between the
circulating blood osteoprotegerin (OPG) level and rheumatoid arthritis (RA), as well as the …

Aim of the work To evaluate the levels of osteoprotegerin (OPG) and receptor activator of the
nuclear factor κB ligand (RANKL), in patients with rheumatoid arthritis (RA) and to study the …

Objective. We determined whether osteoprotegerin (OPG) concentrations are associated
with established cardiovascular disease (CVD) among patients with rheumatoid arthritis …

Osteoporosis represents an important cause of morbidity in adult rheumatoid arthritis (RA)
patients who exhibit increased fracture risk. It is thought that osteoclast and its dysfunction …

Background: Receptor activator of nuclear factor κβ ligand (RANKL) and osteoprotegerin
(OPG) are pivotal molecules involved in osteoclast activation and resorption. In RA, their …

Objective Osteoprotegerin (OPG), a regulator of bone resorption, is involved in the
pathogenesis of rheumatoid arthritis (RA) and atherosclerosis. OPG is elevated in patients …

Objective To test the hypotheses that 1) proinflammatory cytokines affect osteoprotegerin
(OPG) and soluble receptor activator of nuclear factor κB ligand (sRANKL) production and …

Objective: Osteoprotegerin (OPG) is produced by macrophages, dendritic cells and B-cells
in the inflamed synovium of patients with rheumatoid arthritis (RA). It inhibits osteoclast …

Aim of the work The aim of the present study was to investigate the association of serum
osteoprotegerin (OPG) level with the presence of angiographically documented …